| 1 |
Liu W, Ma Z, Wang Y, Yang J. Multiple nano-drug delivery systems for intervertebral disc degeneration: Current status and future perspectives. Bioactive Materials 2023;23:274-299. [DOI: 10.1016/j.bioactmat.2022.11.006] [Reference Citation Analysis]
|
| 2 |
Wadhwa G, Venkata Krishna K, Kumar Dubey S, Taliyan R. Design and biological evaluation of Repaglinide loaded polymeric nanocarriers for diabetes linked neurodegenerative disorder: QbD-driven optimization, in situ, in vitro and in vivo investigation. Int J Pharm 2023;636:122824. [PMID: 36921745 DOI: 10.1016/j.ijpharm.2023.122824] [Reference Citation Analysis]
|
| 3 |
Sanjanwala D, Patravale V. Aptamers and nanobodies as alternatives to antibodies for ligand-targeted drug delivery in cancer. Drug Discov Today 2023;28:103550. [PMID: 36906220 DOI: 10.1016/j.drudis.2023.103550] [Reference Citation Analysis]
|
| 4 |
Wadhwa G, Krishna KV, Dubey SK, Taliyan R. PEGylated Polymer–Lipid Hybrid Nanoparticles to Enhance In Vivo Exposure and Uptake of Repaglinide in Brain Cells to Treat Diabetes-Linked Neurodegenerative Disorders. ACS Appl Nano Mater 2023. [DOI: 10.1021/acsanm.2c05272] [Reference Citation Analysis]
|
| 5 |
Dey A, Kesharwani P, Dubey SK. Actively targeted nanoparticles in photodynamic therapy. Nanomaterials for Photodynamic Therapy 2023. [DOI: 10.1016/b978-0-323-85595-2.00014-1] [Reference Citation Analysis]
|
| 6 |
Kumari S, Bhardwaj JS, Kharavtekar SS, Grewal D, Ray SG, Bhardwaj A, Dubey SK, Kesharwani P, Arora T, Taliyan R. Futuristic aspect of nanocarriers on targeted delivery for dementia. Nanomedicine-Based Approaches for the Treatment of Dementia 2023. [DOI: 10.1016/b978-0-12-824331-2.00005-4] [Reference Citation Analysis]
|
| 7 |
Li L, He R, Yan H, Leng Z, Zhu S, Gu Z. Nanotechnology for the diagnosis and treatment of Alzheimer's disease: A bibliometric analysis. Nano Today 2022;47:101654. [DOI: 10.1016/j.nantod.2022.101654] [Reference Citation Analysis]
|
| 8 |
Hou T, Zhang N, Yan C, Ding M, Niu H, Guan P, Hu X. Curcumin-loaded protein imprinted mesoporous nanosphere for inhibiting amyloid aggregation. Int J Biol Macromol 2022;221:334-45. [PMID: 36084870 DOI: 10.1016/j.ijbiomac.2022.08.185] [Reference Citation Analysis]
|
| 9 |
Pardo-moreno T, González-acedo A, Rivas-domínguez A, García-morales V, García-cozar FJ, Ramos-rodríguez JJ, Melguizo-rodríguez L. Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives. Pharmaceutics 2022;14:1117. [DOI: 10.3390/pharmaceutics14061117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 10 |
Bukhari SNA. Dietary Polyphenols as Therapeutic Intervention for Alzheimer’s Disease: A Mechanistic Insight. Antioxidants 2022;11:554. [DOI: 10.3390/antiox11030554] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
|
